NPA responds to DEA's steroid classification action

In response to the U.S. Justice Department Drug Enforcement Agency's (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic steroids"' under the Controlled Substances Act (CSA), John Gay, executive director and CEO of the Natural Products Association (NPA), the oldest and largest trade association representing retailers and manufacturers of dietary supplements and other natural products, issued the following statement:

"The Natural Products Association and its members are very excited to see the DEA use the additional power the NPA and many others worked so hard to give to it through the Anabolic Steroid Control Act of 2004. The association has maintained all along that federal regulators have the authority they need. The DEA's listing of these three steroids demonstrates that federal regulators can indeed safeguard the shelves against these substances.

"While this was the DEA's first action under the 2004 law, we hope it will not be the last. As it stated at the Senate Judiciary Committee hearing in September on enforcement barriers affecting body building products and hidden steroids, the DEA anticipates that after these first steroids are scheduled it will be easier to follow up with more enforcement and in greater frequency. The Natural Products Association looks forward to working with the agencies as they use this ability to schedule any anabolic steroids that are masquerading as supplements."